Latest Search
Quote
| Back Zoom + Zoom - | ||||
|
JD HEALTH Forges Strategic Partnership with Harbin Pharmaceutical Group
Recommend 10 Positive 10 Negative 1 |
||||
|
||||
|
JD HEALTH (06618.HK) announced that it signed a strategic cooperation agreement with Harbin Pharmaceutical Group. Both parties will deepen collaboration in areas including exclusive launch of new drugs, AI-powered precision recommendations, patient education, and full disease-cycle management, while systematically upgrading scientific nutrition supplements and therapeutic products for all age groups. The two sides have set a clear target of doubling sales over the next three years. Several new products under Harbin Pharmaceutical Group will be exclusively launched on the JD platform. The parties also plan to jointly develop customized products tailored to different age groups and specific health needs. Auto-translated by AI This article was automatically translated by AI, the original language version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation. More Details
AASTOCKS Financial News |
||||
Copied to Clipboard
 |
||||
